Recently, many experimental treatments with anti-inflammatory agents were tested in animal models of AD as well, such as: CHF5074, a non-steroidal anti-inflammatory drug 33; aspirin-triggered LXA4 34; telmisartan 35; cyclooxygenase-1 36; minocycline 37 and several cannabinoids 5. Here, PTGS1 is linked to Alzheimer disease.